Follow
David Eyre
David Eyre
Associate Professor, University of Oxford
Verified email at bdi.ox.ac.uk - Homepage
Title
Cited by
Cited by
Year
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
TM Walker, CLC Ip, RH Harrell, JT Evans, G Kapatai, MJ Dedicoat, ...
The Lancet infectious diseases 13 (2), 137-146, 2013
8242013
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
7682021
Antibody status and incidence of SARS-CoV-2 infection in health care workers
SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ...
New England Journal of Medicine 384 (6), 533-540, 2021
7092021
Diverse sources of C. difficile infection identified on whole-genome sequencing
DW Eyre, ML Cule, DJ Wilson, D Griffiths, A Vaughan, L O'Connor, CLC Ip, ...
N Engl J Med 369, 1195-1205, 2013
6522013
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ...
The Lancet infectious diseases 15 (10), 1193-1202, 2015
5142015
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ...
The Lancet 397 (10286), 1725-1735, 2021
4802021
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ...
The Lancet 397 (10283), 1459-1469, 2021
4162021
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ...
Nature medicine 27 (12), 2127-2135, 2021
3392021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
3352022
A Candida auris Outbreak and Its Control in an Intensive Care Setting
DW Eyre, AE Sheppard, H Madder, I Moir, R Moroney, TP Quan, ...
New England Journal of Medicine 379 (14), 1322-1331, 2018
2852018
Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data
N Stoesser, EM Batty, DW Eyre, M Morgan, DH Wyllie, C Del Ojo Elias, ...
Journal of Antimicrobial Chemotherapy 68 (10), 2234-2244, 2013
2782013
A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance
DW Eyre, T Golubchik, NC Gordon, R Bowden, P Piazza, EM Batty, ...
BMJ open 2 (3), e001124, 2012
2762012
Effects of control interventions on Clostridium difficile infection in England: an observational study
KE Dingle, X Didelot, TP Quan, DW Eyre, N Stoesser, T Golubchik, ...
The Lancet Infectious Diseases 17 (4), 411-421, 2017
2682017
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ...
The Lancet Infectious Diseases 20 (12), 1390-1400, 2020
2412020
Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018
DW Eyre, ND Sanderson, E Lord, N Regisford-Reimmer, K Chau, ...
Eurosurveillance 23 (27), 1800323, 2018
2412018
Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection
AS Walker, DW Eyre, DH Wyllie, KE Dingle, D Griffiths, B Shine, S Oakley, ...
Clinical infectious diseases 56 (11), 1589-1600, 2013
2312013
Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
DW Eyre, AS Walker, D Wyllie, KE Dingle, D Griffiths, J Finney, ...
Clinical Infectious Diseases 55 (suppl_2), S77-S87, 2012
2292012
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ...
The Lancet Public Health 6 (5), e335-e345, 2021
2232021
Characterisation of Clostridium difficile Hospital Ward–Based Transmission Using Extensive Epidemiological Data and Molecular Typing
AS Walker, DW Eyre, DH Wyllie, KE Dingle, RM Harding, L O'Connor, ...
PLoS medicine 9 (2), e1001172, 2012
2122012
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ...
Cell reports 35 (13), 109292, 2021
2082021
The system can't perform the operation now. Try again later.
Articles 1–20